亚太蛋白质定序市场：按应用、最终用户和国家进行分析和预测（2024-2033 年）

亚太地区蛋白质定序市场规模预计将从 2024 年的 3.713 亿美元成长至 2033 年的 6.235 亿美元，预测期内的复合年增长率为 5.93%。

由于对蛋白质体学研究的投资不断增加、生物製药行业不断扩张以及个人化医疗的需求不断增长，亚太地区对蛋白质定序的采用正在加速。两种主要的定序技术分别是适用于较小蛋白质的Edman降解技术和因高通量和分析复杂样本的能力而被广泛用于大规模蛋白质体学的质谱技术。市场包括支援定序过程的仪器、试剂和消耗品，以及提供专门定序服务的CRO。

对生物标记发现、药物开发和疾病诊断的需求不断增长，推动着蛋白质定序技术的不断创新。随着亚太地区政府和私营部门对生命科学的大力投资，该地区有望在蛋白质体学和基于蛋白质的研究方面取得重大进展。

受生命科学投资增加、生技产业不断扩大以及精准医疗需求不断增长的推动，亚太地区的蛋白质定序市场正在快速成长。随着中国、日本、印度和韩国等国家加大对蛋白质体学研究的重视，蛋白质定序在药物发现、疾病诊断和生物标记识别中发挥主导作用。

高解析度质谱和自动Edman降解等定序技术的进步提高了蛋白质分析的准确性和效率。此外，研究机构、製药公司和委外研发机构（CRO）之间的合作正在促进创新并加速市场扩张。

慢性病发病率的不断上升以及对标靶治疗的需求进一步推动了蛋白质定序在生物医学研究中的应用。强而有力的政府支持、不断增加的研发资金和技术进步将显着扩大亚太地区的蛋白质定序市场，塑造该地区个人化医疗和生物製药发展的未来。

市场区隔

细分一：按应用

• 生物治疗
• 基因工程
• 其他的

细分 2：按最终用户

• 学术机构
• 製药公司和 CRO
• 生物技术、诊断和其他公司

细分 3：按地区

• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 其他的

本报告研究了亚太地区的蛋白质定序市场，并总结了主要趋势、影响市场的因素分析、法律制度、技术发展和专利趋势、市场规模趋势和预测、各个细分市场和主要国家的详细分析、竞争格局以及主要企业的概况。

目录

执行摘要

第 1 章亚太蛋白质定序市场概述

• 趋势：当前和未来的影响评估
  • 增加市场上的产品推出
  • 扩大单分子蛋白质定序的应用
  • 生技药品开发需求旺盛
• 蛋白质定序工作流程
  • 蛋白质定序工作流程概述
• 法律规范
  • 日本
  • 中国
• 专利分析
  • 专利申请趋势（按国家）
  • 专利申请趋势（按年份）
• 市场动态概览
  • 市场驱动因素
  • 市场限制
  • 市场机会

2. 亚太地区蛋白质定序市场（依国家）

• 区域摘要
• 亚太地区
  • 区域概况
  • 市场成长推进因素
  • 市场问题
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 其他的

第三章市场：竞争格局

• 蛋白质定序市场：竞争格局
  • 企业策略：2021 年 1 月 - 2024 年 9 月
• 业务策略：2021 年 1 月至 2024 年 9 月
  • 服务/产品发布
• 公司简介
  • FUJIFILM Holdings Corporation
  • Shimadzu Corporation

第四章调查方法

Introduction to Asia-Pacific Protein Sequencing Market

The Asia-Pacific protein sequencing market is projected to reach $623.5 million by 2033 from $371.3 million in 2024, growing at a CAGR of 5.93% during the forecast period 2024-2033. Protein sequencing is the process of identifying the precise order of amino acids in a protein, essential for understanding its structure, function, and role in biological systems. It is crucial in biotechnology, biomedical research, drug discovery, and disease diagnostics, playing a key role in advancing precision medicine and targeted therapies. Protein sequencing provides critical insights into post-translational modifications, protein interactions, and disease mechanisms, supporting breakthroughs in life sciences and healthcare.

In the APAC region, the adoption of protein sequencing is accelerating, driven by increasing investments in proteomics research, expanding biopharmaceutical industries, and rising demand for personalized medicine. The two primary sequencing techniques are Edman degradation, suitable for smaller proteins, and mass spectrometry, widely used for large-scale proteomics due to its high throughput and ability to analyze complex samples. The market includes instruments, reagents, and consumables that enable sequencing processes, along with contract research organizations offering specialized sequencing services.

Growing demand for biomarker discovery, drug development, and disease diagnostics is fostering continuous innovation in protein sequencing technologies. As governments and private sectors in APAC invest heavily in life sciences, the region is poised for significant advancements in proteomics and protein-based research.

Market Introduction

The APAC protein sequencing market is experiencing rapid growth, driven by increasing investments in life sciences, expanding biotechnology sectors, and the rising demand for precision medicine. As countries like China, Japan, India, and South Korea strengthen their focus on proteomics research, protein sequencing is gaining traction in drug discovery, disease diagnostics, and biomarker identification.

Advancements in sequencing technologies, such as high-resolution mass spectrometry and automated Edman degradation, are enhancing the accuracy and efficiency of protein analysis. Additionally, collaborations between research institutions, pharmaceutical companies, and contract research organizations (CROs) are fostering innovation and accelerating market expansion.

The growing prevalence of chronic diseases and the need for targeted therapies further drive the adoption of protein sequencing in biomedical research. With strong government support, increased R&D funding, and technological advancements, the APAC protein sequencing market is set for significant expansion, shaping the future of personalized medicine and biopharmaceutical development in the region.

Market Segmentation:

Segmentation 1: By Application

• Biotherapeutics
• Genetic Engineering
• Others

Segmentation 2: By End User

• Academic Institutes
• Pharma and CROs
• Biotech, Diagnostics, and Other Companies

Segmentation 3: By Region

• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements and emerging applications in protein sequencing, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts, as well as analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Shimadzu Corporation
• FUJIFILM Holdings Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Asia-Pacific Protein Sequencing Market: Overview

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Increasing Product Launches in the Market
  • 1.1.2 Growing Adoption of Single-Molecule Protein Sequencing
  • 1.1.3 High Demand for Biologics Development
• 1.2 Workflow of Protein Sequencing
  • 1.2.1 Protein Sequencing Workflow Overview
• 1.3 Regulatory Framework
  • 1.3.1 Japan
    • 1.3.1.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
    • 1.3.1.2 Regulatory Requirements for Clinical Protein Sequencing Labs in Japan
  • 1.3.2 China
    • 1.3.2.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
• 1.4 Patent Analysis
  • 1.4.1 Patent Filing Trend (by Country)
  • 1.4.2 Patent Filing Trend (by Year)
• 1.5 Market Dynamics Overview
  • 1.5.1 Market Drivers
    • 1.5.1.1 Advancements in Computational Biology and Bioinformatics in the Protein Engineering Market
    • 1.5.1.2 Expanding Applications in Research
    • 1.5.1.3 Technological Advancements in Protein Sequencing
  • 1.5.2 Market Restraints
    • 1.5.2.1 Shortage of Skilled Labour
    • 1.5.2.2 High Cost Hindering the Adoption of Protein Sequencing
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Integration of Artificial Intelligence in Protein Sequencing

2 Asia-Pacific Protein Sequencing Market (by Country), $Million, 2022-2033

• 2.1 Regional Summary
• 2.2 Asia-Pacific
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 China
  • 2.2.5 Japan
  • 2.2.6 India
  • 2.2.7 Australia
  • 2.2.8 South Korea
  • 2.2.9 Rest-of-Asia-Pacific

3 Markets - Competitive Landscape

• 3.1 Protein Sequencing Market: Competitive Landscape
  • 3.1.1 Corporate Strategies, January 2021-September 2024
• 3.2 Business Strategies, January 2021-September 2024
  • 3.2.1 Service/Product Launches
• 3.3 Company Profiles
  • 3.3.1 FUJIFILM Holdings Corporation
    • 3.3.1.1 Overview
    • 3.3.1.2 Top Products
    • 3.3.1.3 Top Competitors
    • 3.3.1.4 Target Customers/End Users
    • 3.3.1.5 Analyst View
  • 3.3.2 Shimadzu Corporation
    • 3.3.2.1 Overview
    • 3.3.2.2 Top Products
    • 3.3.2.3 Top Competitors
    • 3.3.2.4 Target Customers/End Users
    • 3.3.2.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast

List of Figures

• Figure 1: Asia-Pacific Protein Sequencing Market, $Million, 2024, 2028, and 2033
• Figure 2: Asia-Pacific Protein Sequencing Market (by Application), $Million, 2023, 2027, and 2033
• Figure 3: Asia-Pacific Protein Sequencing Market (by End User), $Million, 2023, 2027, and 2033
• Figure 4: Key Events to Keep Track of in the Protein Sequencing Market
• Figure 5: Protein Sequencing Workflow Overview
• Figure 6: Number of Protein Sequencing Patents (by Country), January 2019-May 2024
• Figure 7: Number of Protein Sequencing Patents (by Year), January 2019-May 2024
• Figure 8: Impact Analysis of Market Navigating Factors, 2022-2033
• Figure 9: China Protein Sequencing Market, $Million, 2022-2033
• Figure 10: Japan Protein Sequencing Market, $Million, 2022-2033
• Figure 11: India Protein Sequencing Market, $Million, 2022-2033
• Figure 12: Australia Protein Sequencing Market, 2022-2033
• Figure 13: South Korea Protein Sequencing Market, $Million, 2022-2033
• Figure 14: Rest-of-Asia-Pacific Protein Sequencing Market, $Million, 2022-2033
• Figure 15: Corporate Strategies, January 2021- September 2024
• Figure 16: Product Launches (by Company), January 2021-September 2024
• Figure 17: Data Triangulation
• Figure 18: Top-Down and Bottom-Up Approach
• Figure 19: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Protein Sequencing Market Opportunities
• Table 3: Product Launches, January 2023-September 2024
• Table 4: Companies Providing Single-Molecule Protein Sequencing
• Table 5: List of Molecular Targets Identified with Proteomics
• Table 6: Major Protein Sequencing and Mass Spectrometry Service Fee
• Table 7: Asia-Pacific Protein Sequencing Market (by End User), $Million, 2022-2033
• Table 8: Asia-Pacific Protein Sequencing Market (by Application), $Million, 2022-2033